SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-19-011480
Filing Date
2019-06-26
Accepted
2019-06-26 10:52:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0619kip_enlivexthera.htm SC 13G 34612
  Complete submission text file 0001213900-19-011480.txt   36355
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Subject) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88278 | Film No.: 19920468
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10TH FLOOR ASEM TOWER 517 YEONGDONG-DAERO GANGNAM GU SEUL M5 06164
Business Address 10TH FLOOR ASEM TOWER 517 YEONGDONG-DAERO GANGNAM GU SEUL M5 06164 82-2-6001-5300
KIP Global Pharma-Ecosystem Private Equity Fund (Filed by) CIK: 0001780691 (see all company filings)

IRS No.: 000000000
Type: SC 13G